Benjamin Heyman

Hematology | Oncology

Irvine, CA 92618

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Comparison of Venetoclax-Based Treatments for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia: A Single-Center Real-World Experience.

Comparison of Venetoclax-Based Treatments for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia: A Single-Center Real-World Experience.

Journal: EJHaem

Published: December 15, 2025

Updates on the Treatment of Richter's Syndrome, Including Novel Combination Approaches.

Updates on the Treatment of Richter's Syndrome, Including Novel Combination Approaches.

Journal: Cancers

Published: January 12, 2025

Venetoclax Consolidation After Bruton Tyrosine Kinase Inhibitor Treatment for Patients With Chronic Lymphocytic Leukemia.

Venetoclax Consolidation After Bruton Tyrosine Kinase Inhibitor Treatment for Patients With Chronic Lymphocytic Leukemia.

Journal: EJHaem

Published: December 16, 2024

Antibody Therapy for Patients with Lymphoid Malignancies: Past and Present.

Antibody Therapy for Patients with Lymphoid Malignancies: Past and Present.

Journal: International journal of molecular sciences

Published: December 04, 2024

Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia.

Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia.

Journal: Blood advances

Published: August 12, 2024

Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells.

Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells.

Journal: Journal for immunotherapy of cancer

Published: December 27, 2023

Novel BRAF N581S mutation in mantle cell lymphoma.

Novel BRAF N581S mutation in mantle cell lymphoma.

Journal: EJHaem

Published: October 23, 2023

A + AVD for Treatment of Hodgkin Lymphoma Variant of Richter's Transformation.

A + AVD for Treatment of Hodgkin Lymphoma Variant of Richter's Transformation.

Journal: Case reports in hematology

Published: October 17, 2023

Targeted Therapy in Follicular Lymphoma: Towards a Chemotherapy-Free Approach.

Targeted Therapy in Follicular Lymphoma: Towards a Chemotherapy-Free Approach.

Journal: Cancers

Published: June 12, 2023

Composite Angioimmunoblastic T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma Presenting with Distributive Shock.

Composite Angioimmunoblastic T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma Presenting with Distributive Shock.

Journal: Hematology reports

Published: June 01, 2023

Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologic Malignancies Consortium Retrospective Analysis.

Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologic Malignancies Consortium Retrospective Analysis.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 18, 2023

Obinutuzumab, High-Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients with Richter's Syndrome.

Obinutuzumab, High-Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients with Richter's Syndrome.

Journal: Cancers

Published: October 17, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026